Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-12-11 5:28 pm Purchase | 2020-12-07 | 13D | IGM Biosciences, Inc. IGMS | BAKER BROS. ADVISORS LP | 3,193,022 9.990% | 49,022 (+1.56%) | Filing History |
| 2020-12-04 5:24 pm Sale | 2020-12-01 | 13D | BeiGene, Ltd. ONC | BAKER BROS. ADVISORS LP | 154,315,490 13.000% | -19,650,098 (-11.30%) | Filing History |
| 2020-11-24 4:12 pm Purchase | 2020-11-20 | 13D | Kodiak Sciences Inc. KOD | BAKER BROS. ADVISORS LP | 14,054,698 27.600% | 1,778,949 (+14.49%) | Filing History |
| 2020-09-30 5:25 pm Purchase | 2020-09-24 | 13D | Prelude Therapeutics Incorporated PRLD | BAKER BROS. ADVISORS LP | 10,121,228 31.100% | 10,121,228 (New Position) | Filing History |
| 2020-09-08 5:24 pm Purchase | 2020-09-03 | 13D | Kodiak Sciences Inc. KOD | BAKER BROS. ADVISORS LP | 12,275,749 27.300% | 701,212 (+6.06%) | Filing History |
| 2020-07-28 5:29 pm Purchase | 2020-07-21 | 13D | Kiniksa Pharmaceuticals, Ltd. KNSA | BAKER BROS. ADVISORS LP | 2,903,030 9.200% | 6,253 (+0.22%) | Filing History |
| 2020-07-17 5:22 pm Purchase | 2020-07-12 | 13D | BeiGene, Ltd. ONC | BAKER BROS. ADVISORS LP | 173,965,588 14.900% | 14,846,728 (+9.33%) | Filing History |
| 2020-05-19 5:26 pm Sale | 2020-05-15 | 13D | Seagen Inc. SGEN | BAKER BROS. ADVISORS LP | 47,615,277 27.500% | -1,750,000 (-3.55%) | Filing History |
| 2020-05-18 5:21 pm Purchase | 2020-05-13 | 13D | Kiniksa Pharmaceuticals, Ltd. KNSA | BAKER BROS. ADVISORS LP | 2,896,777 11.500% | 31,268 (+1.09%) | Filing History |
| 2020-05-08 5:23 pm Sale | 2020-05-06 | 13D | Seagen Inc. SGEN | BAKER BROS. ADVISORS LP | 49,365,277 28.500% | -1,058,316 (-2.10%) | Filing History |
| 2020-04-29 4:57 pm Purchase | 2020-04-27 | 13D | Incyte Corporation INCY | BAKER BROS. ADVISORS LP | 32,581,959 15.000% | 30,374 (+0.09%) | Filing History |
| 2020-04-24 4:32 pm Sale | 2020-04-23 | 13D | Seagen Inc. SGEN | BAKER BROS. ADVISORS LP | 50,423,593 29.200% | -881,639 (-1.72%) | Filing History |